Loading clinical trials...
Loading clinical trials...
Study for the Identification of Participants With Liver Steatosis Who Carry Genetic Variants Associated With Nonalcoholic Fatty Liver Disease (NAFLD)
Conditions
Interventions
No intervention
Locations
3
United States
Research Centers of America, LLC
Hollywood, Florida, United States
PRA Health Sciences
Lenexa, Kansas, United States
Endeavor Clinical Trials, LLC
San Antonio, Texas, United States
Start Date
August 7, 2020
Primary Completion Date
October 10, 2022
Completion Date
October 10, 2022
Last Updated
March 30, 2025
NCT00090662
NCT06716502
NCT07310264
NCT06290258
NCT07483606
NCT06342713
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions